El objetivo de este estudio fue determinar si la selección y los resultados de los pacientes tratados con esfinterotomía interna lateral y toxina botulínica para la fisura anal eran equivalentes
Stewart DBS, Gaertner W, Glasgow S, Migaly J, Feingold D, Steele SR. Clinical Practice Guideline for the Management of Anal Fissures. Dis Colon Rectum. United States. 2017 Jan;60(1):7e14.
Perry WB, Dykes SL, Rafferty WD, Rafferty JF. Practice parameters for the management of anal fissures (3rd Revision). Dis Colon Rectum. 2010;53(8): 1110e1115.
Garg P, Garg M, Menon GR. Long term continence disturbance after lateral internal sphincterotomy for chronic anal fissure : a systematic review and meta-analysis. Color Dis. 2013;15(3):104e117.
BOTOX (onabotulinumtoxinA) Product Information. Available from: http:// www.allergan.com/assets/pdf/botox_pi.pdf; 2012.
Chen HL, Woo XB, Wang HS, et al. Botulinum toxin injection versus lateral internal sphincterotomy for chronic anal fissure: a meta-analysis of randomized control trials. Tech Coloproctol. 2014;18(8):693e698.
Wald A. Clinical practice. Fecal incontinence in adults. N Engl J Med. 2007;356: 1648e1655.
Casillas S, Hull TL, Zutshi M, Trzcinski R, Bast JF, Xu M. Incontinence after a lateral internal sphincterotomy: are we underestimating it? Dis Colon Rectum. 2005;48(6):1193e1199.
Jorge JM,Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993;36(1):77e97.
Nasr M, Ezzat H, Elsebae M. Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a randomized controlled trial. World J Surg. 2010:1e5.
Valizadeh N, Jalaly NY, Hassanzadeh M, et al. Botulinum toxin injection versus lateral internal sphincterotomy for the treatment of chronic anal fissure: randomized prospective controlled trial. Langenbeck’s Arch Surg. 2012;397(7): 1093e1098.
Mentes BB, Irkorücü O, Akn M, Leventoglu S, Tatlcoglu E. Comparison of bot